Britain has become the first country to approve Valneva’s inactivated COVID-19 vaccine, which is easier to store than mRNA vaccines and relies on decades-old technology widely used in flu and polio jabs.

Valneva, a French biotech firm, is hoping the shot will appeal to people who are reluctant about getting the Pfizer-BioNTech or Moderna jabs and may prefer a more traditional one.

The UK’s Medicines and Healthcare products Regulatory Agency (MHRA) announced the authorisation on Thursday, saying Valneva’s shot met the required safety, quality and effectiveness standards.

read more

By mo

Leave a Reply

Your email address will not be published.